Skip banner Home   How Do I?   Site Map   Help  
Search Terms: "human cloning", House or Senate or Joint
  FOCUS™    
Edit Search
Document ListExpanded ListKWICFULL format currently displayed   Previous Document Document 90 of 98. Next Document

More Like This

Copyright 2001 eMediaMillWorks, Inc. 
(f/k/a Federal Document Clearing House, Inc.)  
Federal Document Clearing House Congressional Testimony

March 28, 2001, Wednesday

SECTION: CAPITOL HILL HEARING TESTIMONY

LENGTH: 760 words

COMMITTEE: HOUSE ENERGY AND COMMERCE

HEADLINE: TESTIMONY OVERSIGNT OF HUMAN CLONING RESEARCH

TESTIMONY-BY: DR RUDOLF JAENISHCH PH.D. , PROFESSOR OF BIOLOGY MASSACHUSETTS INSTITUTEOF TECHNOLOGY MEMBER

AFFILIATION: WHITEHEAD INSTITUTE

BODY:
March 28, 2001 The House Committee On Energy and Commerce W.J. "Billy" Tauzin, Chairman Subcommittee on Oversight and Investigations Hearing Issues Raised by Human Cloning Research Dr. Rudolf Jaenishch Ph.D. Professor of Biology Massachusetts Institute of Technology Member, Whitehead Institute Summary of Testimony Recently, cloning of humans by nuclear transplantation has been proposed. In this testimony I will focus on the scientific concerns about human cloning that have resulted from the experience with animal cloning. 1. To date, five mammalian species (sheep, mice, goats, cows and pigs) have been cloned, however, survival of the nuclear clones has been uniformly low. The great majority of all clones (of all five species) die either at various stages of embryonic development, at birth, or soon after birth. Most newborn clones are overweight and have an increased and dysfunctional placenta. Those that survive the immediate perinatal period may die within days or weeks after birth with defects such as kidney or brain abnormalities, or with a defective immune system. Even apparently healthy adult clones may have subtle defects that cannot be recognized in the animal. 2. The most likely cause of abnormal clone development is faulty reprogramming of the genome. This may lead to abnormal gene expression of any of the 30,000 genes residing in the animal. 3. Faulty reprogramming does not lead to chromosomal or genetic alterations of the genome, so methods that are used in routine prenatal screening to detect chromosomal or genetic abnormalities in a fetus cannot detect these reprogramming errors. There are no methods available now or in the foreseeable future to assess whether the genome of a cloned embryo has been correctly reprogrammed. 4. The experience with animal cloning allows us to predict with a high degree of confidence that few cloned humans will survive to birth and of those, the majority will be abnormal. The arguments given in this outline have been summarized in more detail in an article by Jaenisch and Wilmut that will be published in Science magazine on March 30, 2001. A copy of the article will be available at the Committee meeting.

LOAD-DATE: March 30, 2001, Friday




Previous Document Document 90 of 98. Next Document
Terms & Conditions   Privacy   Copyright © 2003 LexisNexis, a division of Reed Elsevier Inc. All Rights Reserved.